BioCentury
ARTICLE | Clinical News

P54: Phase IIa

August 26, 2002 7:00 AM UTC

In a U.K. Phase IIa study in 27 steroid dependent patients, of which 16 had ulcerative colitis and 11 had Crohn's disease, P54 did not reduce steroid use compared to placebo. However, in a subgroup (1...